Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
16.01
+1.61 (11.18%)
At close: Jan 6, 2026, 4:00 PM EST
17.40
+1.39 (8.68%)
After-hours: Jan 6, 2026, 7:59 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Small Molecule Precision Medicines
75.62M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
75.62M